FFA
DARE icon

Founders Financial Alliance’s Dare Bioscience DARE Stock Holding History

Founders Financial Alliance’s Portfolio DARE Stock Details DARE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q3 		– Sell
-8,542
Closed -$126K – 484
2022
Q2 		$126K Buy
+8,542
New +$129K 0.06% 243

Other funds holding DARE

FFS
Founders Financial Securities Towson, Maryland $1.77B AUM 17.63% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
SAM
Soviero Asset Management New York $200M AUM 134.59% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Founders Financial Alliance's DARE Position: Q3 2022 in Review

Founders Financial Alliance sold out of Dare Bioscience (DARE) in Q3 2022, closing a stake of 8,542 shares — an estimated $126K sold.

Founders Financial Alliance first reported a position in DARE in Q2 2022 and held it in 1 quarter. The position peaked at $126K in Q2 2022. 31 funds tracked by Wall St. Rank hold DARE as of Q3 2022.

  • Founders Financial Alliance reported no remaining Dare Bioscience position as of Q3 2022 after selling out during the quarter.
  • Founders Financial Alliance sold 8,542 Dare Bioscience shares in Q3 2022, an estimated $126K.
  • Founders Financial Alliance first reported a position in Dare Bioscience in Q2 2022 and held it in 1 quarter.
  • Founders Financial Alliance's Dare Bioscience position peaked at $126K in Q2 2022.
  • 31 funds tracked by Wall St. Rank held Dare Bioscience as of Q3 2022.

Based on Founders Financial Alliance's 13F filing for Q3 2022, filed 14 Nov 2022.